N-methylated cyclic RGD peptides as highly active and selective α(v)β3 integrin antagonists

Journal of Medicinal Chemistry

Volumn 42, Issue 16, 1999, Pages 3033-3040

  Dechantsreiter, Michael A ^a   Planker, Eckart ^a   Mathä, Barbara ^a   Lohof, Elisabeth ^a   Hölzemann, Günter ^b   Jonczyk, Alfred ^b   Goodman, Simon L ^b   Kessler, Horst ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b MERCK KGAA   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

INTEGRIN RECEPTOR; INTEGRIN RECEPTOR ANTAGONIST; UNCLASSIFIED DRUG;

ANGIOGENESIS; ARTICLE; DRUG RECEPTOR BINDING; DRUG SYNTHESIS; MOLECULAR DYNAMICS; STRUCTURE ACTIVITY RELATION;

HUMANS; INTEGRINS; LIGANDS; MAGNETIC RESONANCE SPECTROSCOPY; METHYLATION; MODELS, MOLECULAR; MOLECULAR CONFORMATION; OLIGOPEPTIDES; PEPTIDES, CYCLIC;

EID: 0033549864     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm970832g     Document Type: Article

References (61)

1. Aumailley, M.; Gurrath, M.; Müller, G.; Calvete, J.; Timpl, R.; Kessler, H. Arg-Gly-Asp Constrained within Cyclic Pentapeptides. Strong and Selective Inhibitors of Cell Adhesion to Vitronectin and Laminin Fragment P1. FEBS Lett. 1991, 291, 50-54.
2. Gurrath, M.; Müller, G.; Kessler, H.; Aumailley, M.; Timpl, R. Conformation/Activity Studies of Rationally Designed Potent Anti-Adhesive RGD Peptides. Eur. J. Biochem. 1992, 210, 911-921.
3. Müller, G.; Gurrath, M.; Kessler, H.; Timpl, R. Dynamic Forcing, a Method for Evaluating Activity and Selectivity Profiles of RGD Peptides. Angew. Chem., Int. Ed. Engl. 1992, 31, 326-328.
4. Kessler, H.; Gratias, R.; Hessler, G.; Gurrath, M.; Müller, G. Conformation of Cyclic Peptides. Principle Concepts and the Design of Selectivity and Superactivity in Bioactive Sequences by "Spatial Screening". Pure Appl. Chem. 1996, 68, 1201-1205.
5. Kessler, H.; Diefenbach, B.; Finsinger, D.; Geyer, A.; Gurrath, M.; Goodman, S. L.; Hölzemann, G.; Haubner, R.; Jonczyk, A.; Müller, G.; von Roedern, E. G.; Wermuth, J. Design of Superactive and Selective Integrin Receptor Antagonists Containing the RGD Sequence. Lett. Pept. Sci. 1995, 2, 155-160.
6. 3 Antagonists. J. Am. Chem. Soc. 1996, 118, 7461-7472.
7. 3 Integrin Inhibitor cyclo(-RGDfV-) and Its Retro-Inverso Peptide. J. Am. Chem. Soc. 1997, 119, 1328-1335.
8. Haubner, R.; Schmitt, W.; Hölzemann, G.; Goodman, S. L.; Jonczyk, A.; Kessler, H. Cyclic RGD Peptides Containing β-Turn Mimetics. J. Am. Chem. Soc. 1996, 118, 7881-7891.
9. 3 Integrin for a New Cancer Therapy. Angew. Chem., Int. Ed. Engl. 1997, 36, 1374-1389.
10. 3) Antagonists. J. Med. Chem. 1997, 40, 2289-2292.
11. 3 Antagonists Promote Tumor Regression by Inducing Apoptosis of Angiogenetic Blood Vessels. Cell 1994, 79, 1157-1164.
12. 3 Rescues Melanoma Cells from Apoptosis in 3-Dimensional Dermal Collagen. Proc. Natl. Acad. Sci. U.S.A. 1994, 91, 8856-6860.
13. Ruoslahti, E.; Reed, J. C. Anchorage Dependence, Integrins and Apoptosis. Cell 1994, 77, 477-478.
14. 3-Subunit with Tumor Progression. Cancer Res. 1990, 50, 6757-6764.
15. Zutter, M. M.; Krigman, H. R.; Santoro, S. A. Altered Integrin Expression in Adenocarcinoma of the Breast. Am. J. Pathol. 1993, 142, 1439-1448.
16. Manavalan, P.; Momany, F. A. Conformational Energy Studies on N-Methylated Analogues of Thyrotropin Releasing Hormone, Enkephalin and Luteinizing Hormone Releasing Hormone. Biochemistry 1980, 19, 1943-1973.
17. Tonelli, A. E. The Effects of Isolated N-Methylated Residues on the Conformational Characteristics of Polypeptides. Biopolymers 1976, 15, 1615-1622.
18. Ron, D.; Gilon, C.; Hanani, M.; Vromen, A.; Selinger, Z.; Chorev, M. N-Methylated Analogues of Ac[Nle28,31]CCK(26-33). J. Med. Chem. 1992, 35, 2806-2811.
19. Bach II, A. C.; Eyermann, C. J.; Gross, J. D.; Bower, M. J.; Harlow, R. L.; Weber, P. C.; DeGrado, W. F. Structural Studies of a Family of High Affinity Ligands for GPIIb/IIIa. J. Am. Chem. Soc. 1994, 116, 3207-3219.
20. a-Methyl Amino Acids. J. Med. Chem. 1980, 23, 758-763.
21. Haviv, F.; Fitzpatrick, T. D.; Swenson, R. E.; Nichols, C. J.; Mort, N. A.; Bush, E. N.; Diaz, G.; Bammert, G.; Nguyen, A.; Rhutasel, N. S.; Nellans, H. N.; Hoffman, D. J.; Johnson, E. S.; Greer, J. Effect of N-Methyl Substitution of the Peptide-Bonds in Luteinizing Hormone Releasing Hormone Agonists. J. Med. Chem. 1993, 36, 363-369.
22. Wormser, U.; Laufer, R.; Hart, Y.; Chorev, M.; Gilon, C.; Selinger, Z. Highly Selective Agonists for Substance P Receptor Subtypes. EMBO J. 1986, 5, 2805-2808.
23. Bach II, A. C.; Espina, J. R.; Jackson, S. A.; Stouten, P. F. W.; Duke, J. L.; Mousa, S. A.; DeGrado, W. F. Type II′ to Type I β-Turn Swap Changes Specificity for Integrins. J. Am. Chem. Soc. 1996, 118, 293-294.
24. McDermott, J. R.; Benoiton, N. L. N-Methylamino Acids in Peptide Synthesis. A New Synthesis of N-Benzyloxycarbonyl, N-Methylamino Acids. Can. J. Chem. 1973, 51, 1915-1919.
25. Cheung, S. T.; Benoiton, N. L. N-Methylamino Acids in Peptide Synthesis. Can. J. Chem. 1977, 55, 916-921.
26. Freidinger, R. M.; Hinkle, J. S.; Perlow, D. S.; Arison, B. H. Synthesis of 9-Fluorenylmethyloxycarbonyl-Protected N-Alkyl Amino Acids by Reduction of Oxazolidinones. J. Org. Chem. 1983, 48, 77-81.
27. Merrifield, R. B. Solid-Phase Peptide Synthesis. J. Am. Chem. Soc. 1963, 85, 2149-2154.
28. Merrifield, R. B. Solid-Phase Synthesis. Angew. Chem., Int. Ed. Engl. 1985, 24, 799-810.
29. Fields, G. B.; Noble, R. L. Solid-Phase Peptide Synthesis Utilizing 9-Fluorenylmethoxycarbonyl Amino Acids. Int. J. Pept. Prot. Res. 1990, 35, 161-214.
30. th American Peptide Symposium; Hruby, V. J., Rich, D. H., Eds.; Pierce Chemical Co.: Rockford, IL, 1983; pp 127-130.
31. Simon, R. J.; Kania, R. S.; Zuckermann, R. N.; Huebner, V. D.; Jewell, D. A.; Banville, S.; Ng, S.; Wang, L.; Rosenberg, S.; Marlowe, C. K.; Spellmeyer, D. C.; Tan, R.; Frankel, A. D.; Santi, D. V.; Cohen, F. E.; Bartlett, P. A. Peptoids: A Modular Approach to Drug Discovery. Proc. Natl. Acad. Sci. U.S.A 1992, 89, 9367-9371.
32. Ali, F. E.; Calvo, R.; Romoff, T.; Samanen, J.; Nichols, A.; Store, B. Structure-Activity Studies toward the Improvement of Antiaggregatory Activity of RGDS. In Peptides: Chemistry, Structure and Biology, Rivier, J. E., Marshall, G. R., Eds.; ESCOM Science: Leiden (The Netherlands), 1990; pp 94-96.
33. Fletcher, C. M.; Jones, D. N. M.; Diamond, R.; Neuhaus, D. Treatment of NOE Constraints Involving Equivalent or Non-stereoassigned Protons in Calculations of Biomacromolecular Structures. J. Biol. NMR 1996, 8, 292-310.
34. Havel, T. F. An Evaluation of Computational Strategies for Use in the Determination of Protein Structure from Distance Constraints Obtained by Nuclear Magnetic Resonance. Prog. Biophys. Mol. Biol. 1991, 56, 43-78.
35. Koppitz, M.; Huenges, M.; Gratias, R.; Kessler, H.; Goodman, S. L.; Jonczyk, A. Synthesis of Unnatural Lipophilic N-(9H-Fluoren-9-ylmethoxy)carbonyl-Substituted α-Amino Acids and Their Incorporation into Cyclic RGD-Peptides: A Structure-Activity Study. Helv. Chim. Acta 1997, 80, 1280-1300.
36. Mierke, D. F.; Kurz, M.; Kessler, H. Peptide Flexibility and Calculation of an Ensemble of Molecules. J. Am. Chem. Soc. 1994, 116, 1042-1049.
37. Brooks, C. L. I.; Case, D. A. Simulations of Peptide Conformational Dynamics and Thermodynamics. Chem. Rev. 1993, 93, 2487-2502.
38. Pavone, V.; Benedetti, E.; Di Blasio, B.; Lombardi, A.; Pedone, C. Regularly Alternating L,D-Peptides. III. Hexacyclic Peptides from Valine or Phenylalanine. Biopolymers 1989, 28, 215-223.
39. 1 Integrins. J. Biol. Chem. 1994, 269, 20233-20238.
40. Lohof, E.; Burkhart, F.; Flanker, E.; Mang, C.; Dechantsreiter, M. A.; Hölzemann, G.; Goodman, S.; Kessler, H. Unpublished results.
41. 15N Chemical Shift Referencing in Biomolecular NMR. J. Biomol. NMR 1995, 6, 135-140.
42. Piotto, M.; Saudek, V.; Sklenar, V. Gradient-Tailored Excitation for Single-Quantum NMR Spectroscopy of Aqueous Solution. J. Biomol. NMR 1992, 2, 661-666.
43. Kessler, H.; Schmitt, W. In Encyclopedia of Nuclear Magnetic Resonance; Grant, D. M., Harris, R. K., Eds.; J. Wiley & Sons: New York, 1996; Vol. 6, 3527-3537.
44. Kessler, H.; Seip, S. In Two-Dimensional NMR-Spectroscopy, Applications for Chemists and Biochemists; Croasmun, W. R., Carlson, M. K., Eds.; VCH Publishers: New York, 1994; pp 619-654.
45. 13C Assignments from Sensitivity-Enhanced Detection of Heteronuclear Multiple-Bond Connectivity by 2D Multiple Quantum NMR. J. Am. Chem. Soc. 1986, 108, 2093-2094.
46. Bermel, W.; Wagner, K.; Griesinger, C. Proton-Detected C,H Correlation via Long-Range Couplings with Soft Pulses; Determination of Coupling Constants. J. Magn. Reson. 1989, 83, 223-232.
47. Kessler, H.; Schmieder, P.; Köck, M.; Kurz, M. Improved Resolution in Proton-Detected Heteronuclear Long-Range Correlation. J. Magn. Reson. 1990, 88, 615-618.
48. Jeener, J.; Meier, B. H.; Bachmann, P.; Ernst, R. R. J. Chem. Phys 1979, 71, 4546-4553.
49. Wüthrich, K. In NMR of Proteins and Nuclei Acids; Wiley & Sons: New York, 1986.
50. Bothner-By, A. A.; Stevens, R. L.; Lee, J.; Warren, C. D.; Jeanloz, R. W. Structure Determination of a Tetrasaccharide: Transient Nuclear Overhauser Effects in the Rotating Frame. J. Am. Chem. Soc. 1984, 106, 811-813.
51. Kessler; Griesinger, C.; Kerssebaum, R.; Wagner, K.; Ernst, R. R. Separation of Cross-Relaxation and J Cross-Peaks in 2D Rotating Frame NMR Spectroscopy. J. Am. Chem. Soc. 1987, 109, 607-609.
52. Mueller, L. P. E. COSY. A Simple Alternative to E. COSY. J. Magn. Reson. 1987, 72, 191-196.
53. Mierke, D. F.; Kessler, H. Improved Molecular Dynamics Simulations for the Determination of Peptide Structures. Biopolymers 1993, 33, 1003-1017.
54. Havel, T. F. DISGEO. Quantum Chemistry Exchange Program 1988, Exchange No. 507, Indiana Univeristy.
55. Havel, T. F. The Sampling Properties of Some Distance Geometry Algorithms Applied to Unconstrained Polypeptide Chains: A Study of 1830 Independently Computed Conformations. Biopolymers 1990, 29, 1565-1585.
56. Hagler, A. F.; Lifson, S.; Dauber, P. Consistent Force Field Studies of Intermolecular Forces in Hydrogen-Bonded Crystals. J. Am. Chem. Soc. 1979, 101, 5122-5130.
57. Yatohgo, T.; Izumi, M.; Kashiwagi, H.; Hayashi, M. Novel Purification of Vitronectin from Human-Plasma by Heparin Affinity-Chromatography. Cell Struct. Funct. 1988, 13, 281-292.
58. Kazal, L. A.; Ansel, S.; Miller, O. P.; Tocantins, L. M. Proc. Soc. Exp. Biol. Med. 1963, 113, 989-994.
59. Smith, J. W.; Cheresh, D. A. The Arg-Gly-Asp Binding Domain of the Vitronectin Receptor. J. Biol. Chem. 1988, 263, 18726-18731.
60. v-Integrin Antibody that Blocks Integrin Function Inhibits the Development of a Human-Melanoma in Nude-Mice. Cell Sci. 1995, 108, 2825-2838.
61. Pytela, R.; Pierschbacher, M. D.; Ginsberg, M. H.; Plow, E. F.; Ruoslahti, E. Platelet Membrane Glycoprotein IIb/IIIa-Member of a Family of Arg-Gly-Asp Specific Adhesion Receptors. Science 1986, 231, 1559-1562.